Details of the Drug Reposition

General Information of This Drug (ID: DMIY6DB)

Drug Name
Verteporfin   DMIY6DB
Synonyms Visudyne (TN)
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Exudative age-related macular degeneration DIS88DJO 9B78.3Z Approved [1]
Choroidal neovascularization DISLGVL7 9B76 Approved [1]
Psoriasis vulgaris DIS6M7AN EA90 Approved [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Basal cell nevus syndrome DIST8BC2 2C32 Discontinued in Phase 3 [3]
------------------------------------------------------------------------------------

References

1 Verteporfin FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 ClinicalTrials.gov (NCT00430937) Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections